Impact of completion lymph node dissection on patients with positive sentinel lymph node biopsy in melanoma

Journal of the American College of Surgeons

Volumn 223, Issue 1, 2016, Pages 9-18

  Lee, David Y ^a   Lau, Briana J ^a   Huynh, Kelly T ^a   Flaherty, Devin C ^a   Lee, Ji Hey ^a   Stern, Stacey L ^a   O'Day, Steve J ^a   Foshag, Leland J ^a   Faries, Mark B ^a  

^a SAINT JOHN'S HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BRESLOW THICKNESS; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CHILD; COMPLETE LYMPH NODE DISSECTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY ASSESSMENT; DISTANT METASTASIS FREE SURVIVAL; FEMALE; GENDER; HUMAN; LIMB TUMOR; LOWER LIMB; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MELANOMA; MELANOMA METASTASIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE METASTASIS; SKIN ULCER; SURVIVAL RATE; SURVIVAL TIME; TRUNK; FACTUAL DATABASE; FOLLOW UP; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84969674605     PISSN: 10727515     EISSN: 18791190     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2016.01.045     Document Type: Article

References (40)

1. D.L. Morton, A.J. Cochran, J.F. Thompson, and et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial Ann Surg 242 2005 302 311 discussion 311-313
2. Morton DL, Cagle LA, Wong J, et al. Intraoperative lymphatic mapping and selective lymphadenectomy: technical details of a new procedure for clinical stage I melanoma. 42nd Annual Meeting of the Society of Surgical Oncology, May 20-22, 1990, Washington, DC.
3. D.L. Morton, J.F. Thompson, A.J. Cochran, and et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma N Engl J Med 370 2014 599 609
4. Z.I. Nowecki, P. Rutkowski, A. Nasierowska-Guttmejer, and W. Ruka Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes - one institution's experience Melanoma Res 13 2003 35 43
5. P. Rutkowski, Z.I. Nowecki, A. Nasierowska-Guttmejer, and W. Ruka Lymph node status and survival in cutaneous malignant melanoma - sentinel lymph node biopsy impact Eur J Surg Oncol 29 2003 611 618
6. M. Sladden, S. Zagarella, C. Popescu, and M. Bigby No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report Br J Dermatol 172 2015 566 571
7. M.B. Faries, A.J. Cochran, R.M. Elashoff, and J.F. Thompson Multicenter Selective Lymphadenectomy Trial-I confirms the central role of sentinel node biopsy in contemporary melanoma management: response to 'No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report' Br J Dermatol 172 2015 571 573
8. M.I. Ross, and J.E. Gershenwald How should we view the results of the Multicenter Selective Lymphadenectomy Trial-1 (MSLT-1)? Ann Surg Oncol 15 2008 670 673
9. D.G. Coit, R. Andtbacka, C.J. Anker, and et al. Melanoma, version 2.2013: featured updates to the NCCN guidelines J Natl Compr Canc Netw 11 2013 395 407
10. Z.M. Bamboat, I.T. Konstantinidis, D. Kuk, and et al. Observation after a positive sentinel lymph node biopsy in patients with melanoma Ann Surg Oncol 21 2014 3117 3123
11. T.P. Kingham, K.S. Panageas, C.E. Ariyan, and et al. Outcome of patients with a positive sentinel lymph node who do not undergo completion lymphadenectomy Ann Surg Oncol 17 2010 514 520
12. S.L. Wong, D.L. Morton, J.F. Thompson, and et al. Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study Ann Surg Oncol 13 2006 809 816
13. A.P. van der Ploeg, A.C. van Akkooi, P. Rutkowski, and et al. Prognosis in patients with sentinel node-positive melanoma without immediate completion lymph node dissection Br J Surg 99 2012 1396 1405
14. D.R. Shah, A.D. Yang, E. Maverakis, and S.R. Martinez Age-related disparities in use of completion lymphadenectomy for melanoma sentinel lymph node metastasis J Surg Res 185 2013 240 244
15. S. Pasquali, S. Mocellin, L.G. Campana, and et al. Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases: personal experience and literature meta-analysis Cancer 116 2010 1201 1209
16. S.P. Bagaria, M.B. Faries, and D.L. Morton Sentinel node biopsy in melanoma: technical considerations of the procedure as performed at the John Wayne Cancer Institute J Surg Oncol 101 2010 669 676
17. D.L. Morton, J.F. Thompson, R. Essner, and et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group Ann Surg 230 1999 453 463 discussion 463-465
18. T.G. Zogakis, R. Essner, H.J. Wang, and et al. Melanoma recurrence patterns after negative sentinel lymphadenectomy Arch Surg 140 2005 865 871 discussion 871-872
19. Z.I. Nowecki, P. Rutkowski, and W. Michej The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3) Ann Surg Oncol 15 2008 2223 2234
20. A.C. van Akkooi, M.G. Bouwhuis, J.H. de Wilt, and et al. Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma Br J Surg 94 2007 1293 1299
21. S. Pasquali, A.J. Spillane, J.H. de Wilt, and et al. Surgeons' opinions on lymphadenectomy in melanoma patients with positive sentinel nodes: a worldwide web-based survey Ann Surg Oncol 19 2012 4322 4329
22. K.M. McMasters, S.L. Wong, M.J. Edwards, and et al. Frequency of nonsentinel lymph node metastasis in melanoma Ann Surg Oncol 9 2002 137 141
23. M.S. Sabel, J.D. Rice, K.A. Griffith, and et al. Validation of statistical predictive models meant to select melanoma patients for sentinel lymph node biopsy Ann Surg Oncol 19 2012 287 293
24. M.E. Reeves, R. Delgado, K.J. Busam, and et al. Prediction of nonsentinel lymph node status in melanoma Ann Surg Oncol 10 2003 27 31
25. C. Voit, A.C. Van Akkooi, G. Schafer-Hesterberg, and et al. Ultrasound morphology criteria predict metastatic disease of the sentinel nodes in patients with melanoma J Clin Oncol 28 2010 847 852
26. A. Sanki, R.F. Uren, M. Moncrieff, and et al. Targeted high-resolution ultrasound is not an effective substitute for sentinel lymph node biopsy in patients with primary cutaneous melanoma J Clin Oncol 27 2009 5614 5619
27. B. Singh, S. Ezziddin, H. Palmedo, and et al. Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma Melanoma Res 18 2008 346 352
28. E. Bastiaannet, C.A. Uyl-de Groot, A.H. Brouwers, and et al. Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma Ann Surg 255 2012 771 776
29. J.J. Baker, M.O. Meyers, J. Frank, and et al. Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanoma Am J Surg 207 2014 549 554
30. J.H. Lee, R. Essner, H. Torisu-Itakura, and et al. Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma J Clin Oncol 22 2004 3677 3684
31. M.S. Sabel, K. Griffith, V.K. Sondak, and et al. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma J Am Coll Surg 201 2005 37 47
32. F. Roka, P. Mastan, M. Binder, and et al. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients Eur J Surg Oncol 34 2008 82 88
33. R. Murali, C. Desilva, J.F. Thompson, and R.A. Scolyer Non-Sentinel Node Risk Score (N-SNORE): a scoring system for accurately stratifying risk of non-sentinel node positivity in patients with cutaneous melanoma with positive sentinel lymph nodes J Clin Oncol 28 2010 4441 4449
34. K.P. Wevers, R. Murali, E. Bastiaannet, and et al. Assessment of a new scoring system for predicting non-sentinel node positivity in sentinel node-positive melanoma patients Eur J Surg Oncol 39 2013 179 184
35. R. Feldmann, A.M. Fink, W. Jurecka, and et al. Accuracy of the non-sentinel node risk score (N-SNORE) in patients with cutaneous melanoma and positive sentinel lymph nodes: a retrospective study Eur J Surg Oncol 40 2014 73 76
36. D.L. Morton, J.F. Thompson, A.J. Cochran, and et al. Sentinel-node biopsy or nodal observation in melanoma N Engl J Med 355 2006 1307 1317
37. C. Chao, S.L. Wong, M.I. Ross, and et al. Patterns of early recurrence after sentinel lymph node biopsy for melanoma Am J Surg 184 2002 520 524 discussion 525
38. C.M. Balch, S. Soong, M.I. Ross, and et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial Ann Surg Oncol 7 2000 87 97
39. Kimbrough C, Martin R, McMasters K, et al. Molecular staging of sentinel lymph nodes identifies patients at increased risk of nodal recurrence. Oral presentation at the meeting of the Southern Surgical Association, December 7, 2015, Palm Beach, FL.
40. U. Leiter, R. Stadler, C. Mauch, and et al. Survival of SLNB-positive melanoma patients with and without complete lymph node dissection: a multicenter, randomized DeCOG trial J Clin Oncol 33 suppl; abstract LBA9002 2015